Discovery & Innovation
You’ve just recovered from a mild case of Covid-19 and experienced the usual symptoms: stuffy nose, loss of taste and smell, sore throat…but...
Glioblastoma multiforme (GBM) is one of the most common and difficult-to-treat adult brain tumors. With an estimated 10,000 new US diagnoses per...
From Amazon to Airbnb, Ebay to Etsy, online marketplaces introduced new and innovative ways for people and businesses to connect with each other...
This blog post was adapted from an article written by Nina Culum, MSc, and originally published by InsideScientfic. Acquired immunodeficiency...
As one of the leading providers of custom imaging-based phenotypic assays, PhenoVista Biosciences receives all types of inquiries regarding their...
This blog post was adapted from an article written by Nina Culum, MSc, and originally published by InsideScientfic. The global prevalence of...
This blog post was originally published in Laboratory Animal Science Professional magazine, a publication by the American Association for...
Antimicrobial resistance: The return of an old nemesis Antimicrobial therapies are one of the great human achievements of the 20th century. For...
This panel Q&A was written in collaboration with PhenoVista and highlights their unique service offering, Cell Painting. Learn more about Cell...
We sat down with Meaghan Loy, Category Director, In Vivo Services at Scientist.com, to discuss her perspective on clinical trials and to learn more...
Search
Categories
- Artificial Intelligence (9)
- Challenges (64)
- Discovery & Innovation (199)
- Industry Trends (211)
- Infographics (17)
- News & Events (88)
- Open Science (39)
- Outsourcing (73)
- Press Releases (147)
- Research Exchanges (58)
- Research Services (96)
- Scientist In The News (152)
- Supplier Spotlight (50)
- Tech Snapshot (37)
- Webinars (34)